Ramin I Bukan1, Ann M Møller2, Mattias A S Henning3, Katrine B Mortensen4, Tobias W Klausen5, Tina Waldau6. 1. Herlev University Hospital, Department of Anesthesiology I, Herlev Ringvej 75, 2730 Herlev, Denmark. Electronic address: raminbukan@gmail.com. 2. Herlev University Hospital, Department of Anesthesiology I, Herlev Ringvej 75, 2730 Herlev, Denmark. Electronic address: Ann.Moeller@regionh.dk. 3. Herlev University Hospital, Department of Anesthesiology I, Herlev Ringvej 75, 2730 Herlev, Denmark. Electronic address: bvm646@alumni.ku.dk. 4. University of Copenhagen, Faculty of Health and Medical Science, Blegdamsvej 3B, 2200 Copenhagen N, Denmark. Electronic address: katrinekbm@gmail.com. 5. Herlev University Hospital, Clinical Research Department of Hematology, Herlev Ringvej 75, 2730 Herlev, Denmark. Electronic address: Tobias.Wirenfeldt.Klausen@regionh.dk. 6. Herlev University Hospital, Department of Anesthesiology I, Herlev Ringvej 75, 2730 Herlev, Denmark. Electronic address: Tina.Waldau@regionh.dk.
Abstract
PURPOSE: We sought to investigate whether preadmission quality of life could act as a predictor of mortality among patients admitted to the intensive care unit (ICU). MATERIALS AND METHODS: This is a prospective observational study of all patients above the age of 18 years admitted to the ICU with a length of stay longer than 24 hours. Short form 36 (SF-36) and Acute Physiology and Chronic Health Evaluation II (APACHE II) were used. Mortality was assessed during ICU admission, 30, and 90 days hereafter. RESULTS: We included 318 patients. No patients were lost to follow-up. Using the physical component summary of short form 12 (SF-12) as a predictor of ICU mortality, the area under the curve (0.70; confidence interval, 0.62-0.77) was comparable with that of APACHE II (0.74; confidence interval, 0.67-0.82). The difference between SF-12 and SF-36 was nonsignificant. CONCLUSIONS: Preadmission quality of life, assessed by SF-36 and SF-12, is as good at predicting ICU, 30-, and 90-day mortality as APACHE II in patients admitted to the ICU for longer than 24 hours. This indicates that estimated preadmission quality of life, potentially available in the pre-ICU setting, could aid decision making regarding ICU admission and deserves more attention by those caring for critically ill patients.
PURPOSE: We sought to investigate whether preadmission quality of life could act as a predictor of mortality among patients admitted to the intensive care unit (ICU). MATERIALS AND METHODS: This is a prospective observational study of all patients above the age of 18 years admitted to the ICU with a length of stay longer than 24 hours. Short form 36 (SF-36) and Acute Physiology and Chronic Health Evaluation II (APACHE II) were used. Mortality was assessed during ICU admission, 30, and 90 days hereafter. RESULTS: We included 318 patients. No patients were lost to follow-up. Using the physical component summary of short form 12 (SF-12) as a predictor of ICU mortality, the area under the curve (0.70; confidence interval, 0.62-0.77) was comparable with that of APACHE II (0.74; confidence interval, 0.67-0.82). The difference between SF-12 and SF-36 was nonsignificant. CONCLUSIONS: Preadmission quality of life, assessed by SF-36 and SF-12, is as good at predicting ICU, 30-, and 90-day mortality as APACHE II in patients admitted to the ICU for longer than 24 hours. This indicates that estimated preadmission quality of life, potentially available in the pre-ICU setting, could aid decision making regarding ICU admission and deserves more attention by those caring for critically illpatients.
Authors: Lenka Kielbergerová; Otto Mayer; Jiří Vaněk; Jan Bruthans; Peter Wohlfahrt; Renata Cífková Journal: Transl Stroke Res Date: 2015-08-15 Impact factor: 6.829
Authors: Wytske W Geense; Mark van den Boogaard; Marco A A Peters; Koen S Simons; Esther Ewalds; Hester Vermeulen; Johannes G van der Hoeven; Marieke Zegers Journal: Crit Care Med Date: 2020-09 Impact factor: 9.296